elagolix
Selected indexed studies
- Elagolix. (, 2006) [PMID:30222288]
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. (N Engl J Med, 2017) [PMID:28525302]
- Elagolix: First Global Approval. (Drugs, 2018) [PMID:30194661]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment. (2019) pubmed
- Elagolix. (2006) pubmed
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. (2017) pubmed
- Elagolix: First Global Approval. (2018) pubmed
- Elagolix. (2012) pubmed
- Elagolix in the treatment of endometriosis: impact beyond pain symptoms. (2020) pubmed
- Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis. (2022) pubmed
- Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis. (2020) pubmed
- Elagolix: How far can it go in the world of gynecology? (2023) pubmed
- Use of Elagolix in Gynaecology. (2018) pubmed